Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2534 ARTíCULOS , VIENDO DEL 2521 AL 2534

PUBMED

Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease.

Schwenkgrub J, Joniec-Maciejak I, Sznejder-Pachołek A, Wawer A, Ciesielska A, Bankiewicz K, Członkowska A, Członkowski A.

Pharmacol Rep. 2013;65(1):44-9.

0

0

0

PUBMED

Haptic feedback from manual contact improves balance control in people with Parkinson's disease.

Rabin E, Chen J, Muratori L, DiFrancisco-Donoghue J, Werner WG.

Gait Posture. 2013 Jul;38(3):373-9. doi: 10.1016/j.gaitpost.2012.12.008.

0

0

0

PUBMED

The effects of levodopa and deep brain stimulation on subthalamic local field low-frequency oscillations in Parkinson's disease.

Giannicola G, Rosa M, Marceglia S, Scelzo E, Rossi L, Servello D, Menghetti C, Pacchetti C, Zangaglia R, Locatelli M, Caputo E, Cogiamanian F, Ardolino G, Barbieri S, Priori A.

Neurosignals. 2013;21(1-2):89-98. doi: 10.1159/000336543.

0

0

0

PUBMED

Spread of neuronal degeneration in a dopaminergic, Lrrk-G2019S model of Parkinson disease.

Hindle SJ, Elliott CJ.

Autophagy. 2013 Jun 1;9(6):936-8. doi: 10.4161/auto.24397.

0

0

0

PUBMED

Syncope associated with subthalamic nucleus deep brain stimulation in a patient with Parkinson's disease.

Aygun D, Kocabicak E, Yildiz O, Onar MK, Guz H, Boke O, Kurt M, Temel Y.

Case Rep Neurol Med. 2013;2013:371929. doi: 10.1155/2013/371929.

0

0

0

PUBMED

Exploring the cortical and subcortical functional magnetic resonance imaging changes associated with freezing in Parkinson's disease.

Shine JM, Matar E, Ward PB, Bolitho SJ, Gilat M, Pearson M, Naismith SL, Lewis SJ.

Brain. 2013 Apr;136(Pt 4):1204-15. doi: 10.1093/brain/awt049.

0

0

0

PUBMED

Possible chemical initiators of cognitive dysfunction in phenylketonuria, Parkinson's disease and Alzheimer's disease.

Soloway AH, Soloway PD, Warner VD.

Med Hypotheses. 2013 Oct;81(4):690-4. doi: 10.1016/j.mehy.2013.07.028.

0

0

0

PUBMED

Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.

Sanchez-Danes A, Benzoni P, Memo M, Dell'Era P, Raya A, Consiglio A.

CNS Neurol Disord Drug Targets. 2013 Dec;12(8):1114-27. Review.

0

0

0

PUBMED

[Impulsive-compulsive syndrome in Parkinson's disease].

Nikitina AV, Fedorova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7 Pt 2):32-8. Russian.

0

0

0

PUBMED

History of exposure to dopaminergic medication does not affect motor cortex plasticity and excitability in Parkinson's disease.

Kačar A, Filipović SR, Kresojević N, Milanović SD, Ljubisavljević M, Kostić VS, Rothwell JC.

Clin Neurophysiol. 2013 Apr;124(4):697-707. doi: 10.1016/j.clinph.2012.09.016.

0

0

0

PUBMED

Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease.

Leroi I, Barraclough M, McKie S, Hinvest N, Evans J, Elliott R, McDonald K.

J Neuropsychol. 2013 Sep;7(2):306-25. doi: 10.1111/jnp.12026.

0

0

0

PUBMED

Pitch variability in patients with Parkinson's disease: effects of deep brain stimulation of caudal zona incerta and subthalamic nucleus.

Karlsson F, Olofsson K, Blomstedt P, Linder J, van Doorn J.

J Speech Lang Hear Res. 2013 Feb;56(1):150-8. doi: 10.1044/1092-4388(2012/11-0333).

0

0

0

PUBMED

Update on diffusion MRI in Parkinson's disease and atypical parkinsonism.

Meijer FJ, Bloem BR, Mahlknecht P, Seppi K, Goraj B.

J Neurol Sci. 2013 Sep 15;332(1-2):21-9. doi: 10.1016/j.jns.2013.06.032. Review.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy